Blockchain Registration Transaction Record

NeuroOne Expands Global Patent Portfolio for Neurological Treatments

NeuroOne Medical Technologies expands global patent portfolio with European and US patents for neurological treatments including temperature-controlled brain ablation and minimally invasive spinal stimulation devices.

This development matters because it represents significant advancement in neurological treatment options that could directly impact millions of patients suffering from conditions like epilepsy, Parkinson's disease, and chronic pain. The patented technologies enable less invasive procedures with enhanced safety features, potentially reducing surgical risks, recovery times, and healthcare costs. For patients with drug-resistant epilepsy, the temperature-controlled ablation system offers new hope for seizure control without traditional brain surgery risks. The spinal cord stimulation technology could revolutionize pain management for failed back surgery patients, providing relief without major surgical incisions. These innovations address critical gaps in neurological care where current treatments often involve significant side effects or limited effectiveness, potentially improving quality of life for patients worldwide while advancing the field of neuromodulation therapy.